SAS-J Compared to OAGB and LSG as a Treatment for Morbid Obesity

Morbid Obesity Clinical Trial

Official title:

Single Anastomosis Sleeve Jejunal Bypass Compared to One Anastomosis Gastric Bypass and Sleeve Gastrectomy as a Treatment for Morbid Obesity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03821688
• Other study ID #: fac.med.047
• Status: Completed
• Phase: N/A
• Start date: March 15, 2019
• Est. completion date: August 10, 2020

Study information

• Verified date: December 2021
• Source: Minia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

150 morbidly obese patients divided into to equal groups, group A underwent single anastomosis sleeve jejunal bypass and group B underwent mini gastric bypass, group C underwent sleeve gastrectomy. All patients were followed for at least one year. all cases were evaluated as regard BMI, complications, nutritional status and obesity-related comorbidities.

Description:

150 morbidly obese patients divided into to equal groups, group A underwent single anastomosis sleeve jejunal bypass and group B underwent mini gastric bypass, group C underwent sleeve gastrectomy. All patients were followed for at least one year. all cases were evaluated as regard BMI, complications, nutritional status and obesity-related comorbidities. the minimal follow up period is one year

Recruitment information / eligibility

• Status: Completed
• Enrollment: 210
• Est. completion date: August 10, 2020
• Est. primary completion date: August 10, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• obese patients with BMI more than 40 with or without co-morbidity or more than 35 with co-morbidity

• patients fit for laparoscopic surgery

• give approval to share in the study

Exclusion Criteria:

• patients refused to share in the study

• patients unfit for surgery

• patients aged less than 18 and older than 60

• patient with previous upper abdominal surgery either for obesity or other diseases

• revisional bariatric procedures

Related Conditions & MeSH terms

• Morbid Obesity
• Obesity
• Obesity, Morbid

Intervention

Procedure:
• SAS-JB
single anastomosis sleeve jejunal bypass
• OAGB
one anastomosis gastric bypass
• LSG
laproscopic sleeve gastrectomy

Locations

Country	Name	City	State
Egypt	Faculty of medicine	Minya

Sponsors (1)

Lead Sponsor	Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	percentage of excess weight loss	percentage of excess weight loss in kilogram	12 months
Secondary	the incidence of nutritional deficiency	the incidence of nutritional deficiency like anemia, hypocalcamia, hypoproteinemia.	2 years
Secondary	the rate of improved co morbidity	the effect of the operation on co morbidity like diabetes and hypertension	2 years
Secondary	the incidence of early operative complications	early operative complications like leak, bleeding	one month